Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.54 |
| ▸ | PTPRC | P08575 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.48 |
| ▸ | FEN1 | P39748 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.43 |
| ▸ | TNKS | O95271 | 1/20 | 0.42 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 4/20 | 0.40 |
| ▸ | PGR | P06401 | 2/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6708324 | 0.85 | CDC7 (0.47) | ACMSDPTPRCPTPN1ALOX5APFEN1 | |
| SCHEMBL3097068 | 0.84 | ACMSD (0.51) | ACMSDPTPRCPTPN1ALOX5APFEN1 | |
| SCHEMBL1515817 | 0.82 | CES2 (0.50) | ACMSDPTPRCALOX5APFEN1ALDH1A1 | |
| SCHEMBL6189481 | 0.81 | ACMSD (0.42) | ACMSDPTPRCPTPN1ALOX5APFEN1 | |
| SCHEMBL3093451 | 0.81 | ACMSD (0.42) | ACMSDPTPRCPTPN1ALOX5APFEN1 | |
| SCHEMBL3107192 | 0.80 | ACMSD (0.50) | ACMSDPTPRCPTPN1NPSR1ALDH1A1 | |
| SCHEMBL9723098 | 0.78 | NPSR1 (0.47) | ACMSDPTPRCPTPN1NPSR1ALDH1A1 | |
| SCHEMBL1515697 | 0.78 | ALOX5AP (0.59) | ACMSDALOX5APFEN1MAPTCHEK1 | |
| SCHEMBL14934280 | 0.78 | — | — | |
| SCHEMBL14252244 | 0.76 | ACMSD (0.76) | ACMSDPTPRCPTPN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2084171-B1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | SHOWA DENKO KK (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-20090315454-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | SHOWA DENKO K.K. (JP) | 2009-12-24 | — | — | US | disclosed |
| EP-2084171-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | Showa Denko K.K. (JP) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008056799-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | SHOWA DENKO K.K. (JP) | 2008-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090315454-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | ELP1, RUVBL1, LIG1 | ACMSD 4196/4885PTPRC 3728/4885PTPN1 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.